Clinical Trial Update: The Effects of Synbiotics Supplement on Biochemical Factors and Hepatic Fibrosis in Patients With Nonalcoholic Steatohepatitis [Phase 2, Phase 3]

View source ↗

Summary

This update reports results from Phase 2 and Phase 3 trials evaluating a synbiotic supplement's impact on biochemical factors and hepatic fibrosis in nonalcohol…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Nonalcoholic Steatohepatitis

Drugs mentioned

• Synbiotics supplement (Synbiotics)

Snippet

Sponsor: National Nutrition and Food Technology Institute | Conditions: Non Alcoholic Steatohepatitis | Phase 2, Phase 3 | Status: COMPLETED